47-year-old Michelle Williams and 71-year-old Gill Rich, affected by rare autoimmune liver disease PBC, find hope in recently approved treatment Elafibranor.

Michelle Williams, 47, and Gill Rich, 71, are among those affected by primary biliary cholangitis (PBC), a rare autoimmune liver disease that often goes misdiagnosed, particularly in women. PBC damages bile ducts and can lead to liver failure. With around 25,000 cases in the UK, recent approval of Elafibranor, a new treatment, offers hope for improved management, especially for patients unresponsive to standard therapies. Both women advocate for awareness and support.

October 28, 2024
3 Articles